A retrospective study of late outcome in patients with peripheral arterial occlusive disease: An association between prosthetic vascular graft and cancer death?

Angiology

Volumn 50, Issue 12, 1999, Pages 1007-1015

  Yoshitomi, Yuji ^a   Kojima, Shunichi ^a   Umemoto, Takuya ^a   Hosoi, Yasuo ^a   Kuramochi, Morio ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CANCER MORTALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

EID: 0032763192     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905001206     Document Type: Article

References (25)

1. Creager MA, Dzau VJ: Vascular diseases of the extremities. In: Harrison's principles of internal medicine, ed. 13, ed. by Isselbacher KJ, Braunwald E, Wilson JD, et al. New York: McGraw-Hill, 1994, pp 1135-1137.
2. Veith FJ, Gupta SK, Samson RH, et al: Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures. Ann Surg 194:386-401, 1981.
3. Veith FJ, Gupta SK, Wengerter KR, et al: Changing arteriosclerotic disease patterns and management strategies in lower limb-threatening ischemia. Ann Surg 212:402-414, 1990.
4. Tillgren C: Obliterative arterial disease of the lower limbs. Acta Medica Scand 178:103-119, 1965.
5. Källero KS: Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography: A ten-year follow-up study. J Chron Dis 34:455-462, 1981.
6. Neugebauer J, Heyn G: Survival rates after reconstructions in the aorto-iliac region. J Cardiovasc Surg 23:229-230, 1982.
7. Van den Akker PJ, van Schilfgaarde R, Brand R, et al: Long-term success of aortoiliac operation for arteriosclerotic obstructive disease. Surg Gynecol Obstet 174:485-496, 1992.
8. Cox DR: Regression model and life tables. J R Stat Soc B34:187-220, 1972.
9. Kannel WB, McGee DL: Update on some epidemiologic features of intermittent claudication: The Framingham study. J Am Geriatr Soc 33:13-18, 1985.
10. Crawford ES, Bomberger RA, Glaeser DH, et al: Aortoiliac occlusive disease: Factors influencing survival and function following reconstructive operation over a twenty-five-year period. Surgery 90:1055-1067, 1981.
11. Cron JP, Cron C, Blanchard D, et al: Long-term of patients receiving an aorto-bi-femoral prosthesis for atherosclerotic occlusion disease of the aortic bifurcation. Im Angiol 13:300-307, 1994.
12. Brand KG: Cancer associated with absestosis, schistosomiasis, foreign bodies, and scars. In: Cancer 1. A. Comprehensive Treatise, ed. by Becker FF. New York: Plenum Press, 1982, pp 661-692.
13. Brand KG, Johnson KH, Buoen LC: Foreign body tumorigenesis. CRC Crit Rev Toxicol 5:353-394, 1976.
14. Schoen FJ: Biomaterial-associated infection, neoplasia, and calcification: Clinicopathologic features and pathophysiologic concepts. Trans Am Soc Artif Intern Organs 33:8-18, 1987.
15. Clowes AW, Kirkman TR, Reidy MA: Mechanisms of arterial graft healing: Rapid transmural capillary in-growth provides a source of intimai endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol 123:220-230, 1986.
16. Clowes AW, Kirkman TR, Clowes MM: Mechanisms of arterial graft failure II: Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J Vasc Surg 3:877-884, 1986.
17. Graham LM: Growth factor production following prosthetic graft implantation. J Vasc Surg 13:742-744, 1991.
18. Ross R, Bowen-Pope DF, Raines EW: Platelet-derived growth factor and its role in health and disease. Phil Trans R Soc Lond B327:155-169, 1990.
19. Kaufman BR, DeLuca DJ, Folsom DL, et al: Elevated platelet-derived growth factor production by aortic grafts implanted on a long-term basis in a canine model. J Vasc Surg 15:806-816, 1992.
20. Westermark B, Heldin C-H: Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta Oncologica 32:101-105, 1993.
21. Kalman PG, Rotstein OD, Niven J, et al: Differential stimulation of macrophage procoagulant activity by vascular grafts. J Vasc Surg 17:531-537, 1993.
22. Urayama H, Kasashima F, Kawakami T, et al: An immunohistochemical analysis of implanted woven Dacron and expanded polytetrafluoroethylene grafts in humans. Artif Organs 20:24-29, 1996.
23. Gordon S: The mononuclear phagocyte system and tissue homeostasis. In: Oxford Textbook of Medicine, ed. 3, ed. by Ledingham GG, Weatherall DJ, Warrell DA. New York: Oxford University Press, 1996, pp 84-95.
24. Cerutti PA: Prooxidant states and tumor promotion. Science 227:375-381, 1985.
25. Oberley LW, Buettner GR: Role of superoxide dismutase in cancer: A review. Cancer Res 39:1141-1149, 1979.